Zacks Investment Research cut shares of Axcella Health (NASDAQ:AXLA – Get Rating) from a buy rating to a hold rating in a research note released on Tuesday morning, Zacks.com reports. According to Zacks, “Axcella Health Inc. is a biotechnology company. It is engaged in the research and development of novel multifactorial interventions to support health […]